UC
Upadacitinib Appears Safe, Effective In Older Adults With UC
Upadacitinib is safe for adults 50 years of age and older with moderate to severe UC, according to retrospective ...
AUGUST 7, 2025
Subcutaneous Infliximab Found Effective With or Without an Immunosuppressant
Patients who achieved a clinical response to subcutaneous infliximab showed no meaningful differences in outcomes ...
APRIL 30, 2025
A Miss for FMT in Ulcerative Colitis, Additional Upadacitinib Benefits in Crohn’s
This month’s report looks at two distinct issues: fecal microbiota transplantation and upadacitinib.
SEPTEMBER 27, 2024
FDA Approves Guselkumab for UC
The FDA has approved guselkumab (Tremfya, Janssen) for patients with moderately to severely active ulcerative ...
SEPTEMBER 12, 2024
Data From Wearables Can Indicate Flares in Patients With IBD
Data collected by wearables, such as an Apple Watch, Fitbit or Oura Ring, can help uncover flares in people with UC ...
AUGUST 6, 2024
Subcutaneous Infliximab or Vedolizumab For Maintenance Therapy in IBD; Fast-Acting Upadacitinib in Crohn’s
In this month’s The Regueiro Report, I highlight two studies on medications to treat inflammatory bowel ...
JUNE 27, 2024
FDA Approves Risankizumab for Ulcerative Colitis
The FDA has approved risankizumab (Skyrizi, AbbVie) for patients with moderate to severe ulcerative colitis.
JUNE 27, 2024
Anti–IL-23 Agents Effective After Prior UC Treatment Failure
VANCOUVER, B.C.—Two different monoclonal antibodies targeting the interleukin-23 p19 subunit achieved all of ...
JANUARY 26, 2024
FDA Approves Subcutaneous Vedolizumab for Moderate to Severe UC
The FDA has approved a subcutaneous version of Entyvio for maintenance therapy in adults with moderate to severe ...
OCTOBER 6, 2023
In UC, Tofacitinib and Ustekinumab Perform Similarly After Biologic Failure
In biologic-experienced patients with ulcerative colitis, tofacitinib and ustekinumab achieve about the same rate ...
MAY 17, 2023
Disconnect Between ACG/AGA Guidelines and Insurance Policies on IBD Biologics
Many major insurance companies do not adhere to the most recent recommendations on IBD treatment from the ACG and ...
MARCH 17, 2023
Subcutaneous Infliximab And the FODMAP Diet
Although infliximab is one of the oldest therapies for IBD, first approved by the FDA for the treatment of ...
DECEMBER 14, 2022
